The American Diabetes Association takes millions from companies that stand to profit from our reliance on drugs. Is that affecting their guidance?
For a glimpse into how big business influences the $4tn US healthcare system, look no further than the world’s most powerful diabetes advocacy and research non-profit, the American Diabetes Association (ADA).
Diabetes afflicts 38 million Americans, with another 90 million considered pre-diabetic. Every year the disease claims the lives of over 100,000 Americans and disproportionately affects people of color. It is also ruinously expensive, as doctors visits, hospital stays, insulin, blood test strips, leg amputations, continuous glucose monitors and numerous glucose-lowering drugs add up to about $400bn a year. To put it bluntly, we are losing the war on diabetes.
